Crocs is cheap and there's growth potential if Heydude makes a turnaround.Crocs (CROX 1.40%) has struggled over the past few years under the weight of a Heydude acquisition that didn't go according to plan. But Heydude is close to turning toward growth and Crocs is buying back shares at a compelling price of 6.6x earnings, which could make this a long-term winner for investors.*Stock prices used were end-of-day prices of March 24, 2025. The video was published on March 26, 2025. ...

Core Viewpoint - A lawsuit has been filed against Crocs, Inc. and its senior executives for potential violations of federal securities laws, specifically related to misleading statements about the company's inventory practices and revenue growth from its acquisition of HEYDUDE [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Delaware, captioned Carretta v. Crocs, Inc., et al., No. 25-cv-00096, and claims are made under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until March 24, 2025, to request to be appointed to lead the case [2]. Group 2: Allegations Against Crocs - Crocs's CEO, Andrew Rees, allegedly assured investors that the company would not overstock wholesalers, but it is claimed that HEYDUDE's revenue growth was largely due to Crocs aggressively stocking its third-party wholesaler pipeline, regardless of actual retail demand [3]. - The company revealed on April 27, 2023, that much of HEYDUDE's revenue growth was not indicative of actual retail sales, leading to a stock price decline of $23.46 per share, or nearly 16%, from $147.78 to $124.32 [4]. Group 3: Financial Performance and Stock Impact - On October 29, 2024, Crocs reported disappointing Q3 2024 results, attributing struggles at HEYDUDE to excess inventories and admitting to shipping too much product in 2022, which led to a stock price decline of $26.47 per share, or approximately 19%, from $138.05 to $111.58 [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Crocs, Inc. regarding a class action lawsuit alleging misleading statements and failure to disclose critical information about the company's revenue growth and inventory management during a specified period [1][2]. Summary by Sections Allegations - The lawsuit claims that during the class period from November 3, 2022, to October 28, 2024, Crocs, Inc. made materially false and misleading statements regarding the sustainability of HEYDUDE's revenue growth, which was largely driven by stocking third-party wholesalers and retailers after its acquisition in February 2022 [1]. - It is alleged that as retail partners began to destock excess inventory, the demand for products decreased, negatively impacting Crocs' financial results [1]. - The representations made by the defendants about the company's business operations and prospects were claimed to be materially false and misleading, lacking a reasonable basis [1]. Next Steps for Shareholders - Shareholders who purchased shares of CROX during the specified timeframe are encouraged to register for the class action, with a deadline set for March 24, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates throughout the case lifecycle [2]. Firm's Commitment - The Gross Law Firm is recognized nationally for its commitment to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Crocs, Inc. for misleading investors regarding the sustainability of revenue growth from its HEYDUDE acquisition, which significantly impacted the company's stock price [1][3][4]. Group 1: Lawsuit Details - The lawsuit was filed by Kessler Topaz Meltzer & Check, LLP on behalf of investors who acquired Crocs common stock between November 3, 2022, and October 28, 2024 [1]. - Investors have until March 24, 2025, to move the Court to serve as lead plaintiff for the class [2][8]. - The case is titled Carretta v. Crocs, Inc., et al., and was filed in the United States District Court for the District of Delaware [1]. Group 2: HEYDUDE Acquisition and Revenue Misrepresentation - Crocs acquired HEYDUDE in February 2022, and HEYDUDE accounted for approximately 25% of Crocs' total revenues in 2022 [2]. - The revenue growth from HEYDUDE was largely due to Crocs' strategy of overstocking third-party wholesalers, which misled investors about actual retail demand [3]. - CEO Andrew Rees assured investors that Crocs would not engage in overstocking, contradicting the company's actions [3]. Group 3: Impact on Stock Price - On April 27, 2023, after revealing the unsustainable nature of HEYDUDE's revenue growth, Crocs' stock price fell by $23.46, or nearly 16% [4]. - Following the third quarter 2024 earnings call on October 29, 2024, where further issues regarding HEYDUDE's performance were disclosed, the stock price dropped by $26.47, or approximately 19.2% [6][7]. Group 4: Investor Actions - Investors who suffered losses are encouraged to contact Kessler Topaz Meltzer & Check, LLP for more information [8][10]. - A lead plaintiff is a representative party who acts on behalf of all class members, typically the investor with the largest financial interest [9].

Group 1 - The article advocates for investors to rotate their portfolios into smaller-cap value stocks, particularly those with independent catalysts [1] - The author, Gary Alexander, has extensive experience in covering technology companies and has been involved with seed-round startups, providing insights into current industry themes [1] Group 2 - The article does not provide any specific financial data or performance metrics related to the companies discussed [2][3]

Core Points - Rosen Law Firm is reminding investors who purchased Crocs, Inc. common stock between November 3, 2022, and October 28, 2024, of the March 24, 2025, lead plaintiff deadline for a class action lawsuit [1][2] - The lawsuit alleges that Crocs failed to disclose critical information regarding the sustainability of HEYDUDE's revenue growth and the impact of destocking by retail partners on Crocs' financial results [4] Group 1 - The class action lawsuit has already been filed, and investors can join without any out-of-pocket fees through a contingency fee arrangement [1][2] - Investors wishing to serve as lead plaintiff must file a motion with the Court by March 24, 2025 [2] - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] Group 2 - The lawsuit claims that Crocs misled investors about its business operations and prospects, leading to financial damages when the true details were revealed [4] - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone [3]

The growth of Crocs ( CROX ) has amazed me over the years, as this was always considered to be "ugly" footwear -- at least around the people I would hang out with. Yet, the company has remained strong, with record revenues in 2024. However, the stock isI objectively search for undervalued stocks of any size across a wide variety of industries using quantitative methods that I've thoroughly backtested for success. I believe the numbers are more important than the story (most of the time), as they tend to pai ...

Group 1: ESSA Pharma Inc. (NASDAQ:EPIX) - The class period for the lawsuit is from December 12, 2023, to October 31, 2024, with a lead plaintiff deadline of March 25, 2025 [2] - The complaint alleges that defendants made materially false and misleading statements regarding the efficacy of masofaniten in combination with enzalutamide for treating prostate cancer [2] - Key allegations include that the combination treatment had no clear efficacy benefit over enzalutamide alone and that the M-E Combination Study was unlikely to meet its primary endpoint [2] Group 2: Cardlytics, Inc. (NASDAQ:CDLX) - The class period for the lawsuit is from March 14, 2024, to August 7, 2024, with a lead plaintiff deadline of March 25, 2025 [3] - The lawsuit claims that defendants made false statements regarding the company's ability to increase billings in line with rising consumer engagement [3] - Allegations include that changes to Cardlytics' Ads Decision Engine led to "underdelivery" of budgets and customer billing estimates, resulting in misleading positive statements about the company's prospects [3] Group 3: Novo Nordisk A/S (NYSE:NVO) - The class period for the lawsuit is from November 2, 2022, to December 19, 2024, with a lead plaintiff deadline of March 25, 2025 [4] - The complaint alleges that defendants created a false impression of reliable information regarding the success of the phase 3 CagriSema study on obesity [4] - Key points include that the optimistic claims about achieving at least 25% weight loss were misleading and that the study's flexible protocol limited its ability to provide effective weight loss data [4] Group 4: Crocs, Inc. (NASDAQ:CROX) - The class period for the lawsuit is from November 3, 2022, to October 28, 2024, with a lead plaintiff deadline of March 24, 2025 [6] - The lawsuit alleges that defendants misrepresented the revenue growth of HEYDUDE, claiming it was driven by management's decision to stock wholesalers aggressively, regardless of retail demand [6]

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Crocs (CROX) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Crocs currently has an average brokerage reco ...

Core Viewpoint - A class action lawsuit has been filed against Crocs, Inc. for allegedly making false and misleading statements regarding the sustainability of revenue growth from its HEYDUDE acquisition, leading to investor losses [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of the Securities Exchange Act of 1934, specifically §§10(b) and 20(a), and Rule 10b-5 [1]. - Investors who purchased Crocs securities between November 3, 2022, and October 28, 2024, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against Crocs - The complaint alleges that Crocs misled the market about the sustainability of revenue growth from HEYDUDE, which was acquired in February 2022 [4]. - The revenue growth was reportedly driven by stocking excess inventory with third-party wholesalers and retailers, which later led to falling demand as retail partners began to destock [4]. - As a result of these misleading statements, when the truth emerged, investors suffered financial damages [4].